Cartesian Therapeutics, Inc. (RNAC)

6.45 -0.30 (-4.44%) USD  |  NASDAQ  |  May 26, 16:00
6.65 +0.20 (+3.10%) Pre-Market: 08:08
More

Cartesian Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for RNAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Precision BioSciences, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade